CompletedPhase 4NCT02166853
Effects of SEvoflurane on Gas Exchange and Inflammation in Patients With ARDS (SEGA Study)
Studying Subependymal giant cell astrocytoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Clermont-Ferrand
- Principal Investigator
- Matthieu JABAUDONUniversity Hospital, Clermont-Ferrand
- Intervention
- sevoflurane(drug)
- Enrollment
- 50 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2014 – 2016
Study locations (1)
- CHU Clermont-Ferrand, Clermont-Ferrand, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02166853 on ClinicalTrials.gov